Insider Transactions in Q2 2024 at Ventyx Biosciences, Inc. (VTYX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Somu Subramaniam |
SELL
Other acquisition or disposition
|
Indirect |
641,327
-8.28%
|
-
|
|
Jun 24
2024
|
Nsv Partners Iii LP |
SELL
Other acquisition or disposition
|
Indirect |
641,327
-8.28%
|
-
|
|
Jun 10
2024
|
Raju Mohan CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
96,778
+5.46%
|
$0
$0.2 P/Share
|
|
Apr 12
2024
|
Somu Subramaniam |
SELL
Other acquisition or disposition
|
Indirect |
695,339
-8.24%
|
-
|
|
Apr 12
2024
|
Nsv Partners Iii LP |
SELL
Other acquisition or disposition
|
Indirect |
695,339
-8.24%
|
-
|
|
Apr 02
2024
|
Christopher W Krueger CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,651
-0.58%
|
$8,255
$5.4 P/Share
|
|
Apr 02
2024
|
Martin Auster CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,405
-5.47%
|
$7,025
$5.4 P/Share
|
|
Apr 02
2024
|
Raju Mohan CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,312
-0.27%
|
$21,560
$5.4 P/Share
|
|
Apr 02
2024
|
John Nuss CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,651
-0.62%
|
$8,255
$5.4 P/Share
|